Shoshana Levy

Publications

• A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity. Ng PP, Jia M, Patel KG, Brody JD, Swartz JR, Levy S, Levy R. Proc Natl Acad Sci U S A. 2012; 109 (36): 14526-31
• Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81. Sagi Y, Landrigan A, Levy R, Levy S. Proc Natl Acad Sci U S A. 2012; 109 (5): 1613-8
• Self-antigen recognition by follicular lymphoma B-cell receptors. Sachen KL, Strohman MJ, Singletary J, Alizadeh AA, Kattah NH, Lossos C, Mellins ED, Levy S, Levy R. Blood. 2012; 120 (20): 4182-90
• The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes. Vences-Catalán F, Rajapaksa R, Levy S, Santos-Argumedo L. Immunology. 2012; 137 (1): 48-55
• A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors. Goldstein MJ, Varghese B, Brody JD, Rajapaksa R, Kohrt H, Czerwinski DK, Levy S, Levy R. Blood. 2011; 117 (1): 118-27
• Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphoma. Patel KG, Ng PP, Levy S, Levy R, Swartz JR. Protein Expr Purif. 2011; 75 (1): 15-20